Cargando…

(18)F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models

We evaluated the relationship between pre-treatment positron emission tomography (PET) using the hypoxic tracer (18)F-[2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3- pentafluoropropyl) acetamide] ((18)F-EF5) and the response of preclinical tumor models to a range of fractionated radiotherapies. Subcuta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Rehan, Apte, Sandeep, Vilalta, Marta, Subbarayan, Murugesan, Miao, Zheng, Chin, Frederick T., Graves, Edward E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592127/ https://www.ncbi.nlm.nih.gov/pubmed/26431331 http://dx.doi.org/10.1371/journal.pone.0139425

Ejemplares similares

(18) F-click labeling and preclinical evaluation of a new (18) F-folate for PET imaging
por: Schieferstein, Hanno, et al.
Publicado: (2013)

Simplified and accessible [(18)F]F‐AraG synthesis procedure for preclinical PET
por: Högnäsbacka, Antonia A., et al.
Publicado: (2022)

Repeatability of tumour hypoxia imaging using [(18)F]EF5 PET/CT in head and neck cancer
por: Silvoniemi, Antti, et al.
Publicado: (2017)

The feasibility of [(18)F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study
por: Laasik, Maren, et al.
Publicado: (2020)

Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies
por: Mittra, Erik S., et al.
Publicado: (2016)

Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe (18)F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma
por: Murayama, Chieko, et al.
Publicado: (2017)

Preclinical Evaluation of [(18)F]FACH in Healthy Mice and Piglets: An (18)F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET
por: Gündel, Daniel, et al.
Publicado: (2021)

Synthesis and Preclinical Characterization of [(18)F]FPBZA: A Novel PET Probe for Melanoma
por: Wu, Shih-Yen, et al.
Publicado: (2014)

Evaluation of 2-[(18)F]-Fluorodeoxysorbitol PET Imaging in Preclinical Models of Aspergillus Infection
por: Lai, Jianhao, et al.
Publicado: (2021)

Evaluation of repeated [(18)F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas
por: Silvoniemi, Antti, et al.
Publicado: (2014)

Precision Radiotherapy: (18)F-FDG PET-based radiotherapy planning in Head and Neck cancers
por: Subramanyam, Padma, et al.
Publicado: (2020)

Preclinical and clinical study on [(18)F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease
por: Xu, MiaoMiao, et al.
Publicado: (2021)

Technical feasibility of [(18)F]FET and [(18)F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model
por: Verhoeven, Jeroen, et al.
Publicado: (2019)

Human Organotypic Lung Tumor Models: Suitable For Preclinical (18)F-FDG PET-Imaging
por: Fecher, David, et al.
Publicado: (2016)

Comparison of [(18)F]FIMP, [(11)C]MET, and [(18)F]FDG PET for early-phase assessment of radiotherapy response
por: Nozaki, Satoshi, et al.
Publicado: (2023)

A preclinical model for phenogroup 3 HFpEF
por: Yousefi, Keyvan, et al.
Publicado: (2019)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Preclinical PET imaging of HIP/PAP using 1'-(18)F-fluoroethyl-β-D-lactose
por: Yao, Shaobo, et al.
Publicado: (2017)

Preclinical characterization of [(18)F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase
por: Koike, Tatsuki, et al.
Publicado: (2021)

Imaging Adipose Tissue Browning using Mitochondrial Complex-I Tracer [(18)F]BCPP-EF
por: Goggi, Julian L., et al.
Publicado: (2022)

[(18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
por: Ballweg, Anna, et al.
Publicado: (2023)

Parametric methods for [(18)F]flortaucipir PET
por: Golla, Sandeep SV, et al.
Publicado: (2018)

Is C‐11 Methionine PET an alternative to 18‐F FDG‐PET for identifying recurrent laryngeal cancer after radiotherapy?
por: Wedman, Jan, et al.
Publicado: (2018)

TSPO–PET imaging using [(18)F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75(NTR) ligand LM11A-31
por: Simmons, Danielle A, et al.
Publicado: (2018)

Tolerating Large Preclinical Models of HFpEF But Without the Intolerance?
por: Justo da Silva, Gustavo Jose, et al.
Publicado: (2021)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

(18)F-FDG-labeled red blood cell PET for blood-pool imaging: preclinical evaluation in rats
por: Matsusaka, Yohji, et al.
Publicado: (2017)

(18)F-FDG PET/MRI Imaging in a Preclinical Rat Model of Cardiorenal Syndrome—An Exploratory Study
por: Furcea, Dan Mihai, et al.
Publicado: (2022)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

Preclinical evaluation and pilot clinical study of [(18)F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts
por: Hu, Kongzhen, et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
por: Chen, Yei-Tsung, et al.
Publicado: (2019)

Integrating Small Animal Irradiators with Functional Imaging for Advanced Preclinical Radiotherapy Research
por: Ghita, Mihaela, et al.
Publicado: (2019)

Differences in in vitro microglial accumulation of the energy metabolism tracers [(18)F]FDG and [(18)F]BCPP-EF during LPS- and IL4 stimulation
por: Suzuki, Chie, et al.
Publicado: (2021)

Preclinical and first-in-human-brain-cancer applications of [(18)F]poly (ADP-ribose) polymerase inhibitor PET/MR
por: Young, Robert J, et al.
Publicado: (2020)

Preclinical evaluation of [(18)F]FDG-PET as a biomarker of lymphoid tissue disease and inflammation in Zika virus infection
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2022)

Hypoxia imaging with (18)F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
por: Melsens, Elodie, et al.
Publicado: (2018)

The (18)F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes
por: Choi, Jinhyun, et al.
Publicado: (2018)

(18)F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy
por: Helsen, Nils, et al.
Publicado: (2017)

Implications of the Harmonization of [(18)F]FDG-PET/CT Imaging for Response Assessment of Treatment in Radiotherapy Planning
por: Jiménez-Ortega, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eslklacq9fl31i2nssgikhcofg